In a unique collaboration with Canada’s leading mining investment bank Red Cloud Securities, we bring you 4 amazing speakers. Canadian-listed Consolidated Uranium have 13 projects across 4 countries. Canadian-listed E3 lithium are developing lithium from brine in Canada. Sigma Lithium Corp are developing potentially the world’s 4th largest lithium mine in Brazil. And David Talbot, top mining analyst at Red Cloud talks us through the metal supercycles. Please register here.  

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOpen Orphan Share News (ORPH)

Share Price Information for Open Orphan (ORPH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.54
Bid: 11.00
Ask: 11.70
Change: 0.54 (4.91%)
Spread: 0.70 (6.36%)
Open: 11.50
High: 11.54
Low: 11.54
Prev. Close: 11.54
ORPH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
14 Jun 22 15:42

Open Orphan wins £7.2m contract for RSV human study

(Sharecast News) - Contract research organisation Open Orphan announced on Tuesday that iits subsidiary hVIVO has signed a £7.2m contract with an existing global pharmaceutical company to test it...

Read more
14 Jun 22 14:12

Open Orphan's hVIVO wins GBP7.2 million RSV contract

(Alliance News) - Open Orphan PLC on Tuesday said its subsidiary hVIVO Ltd has won a GBP7.2 million contract, marking the company's third win since May 18....

Read more
7 Jun 22 11:48

IN BRIEF: Open Orphan swings to profit in 2021 on record contract wins

Open Orphan PLC - London-based pharmaceutical services - Swings to pretax profit of GBP277,000 in 202, from a loss of GBP11.0 million. Revenue rises 74% to GBP39.0 million from GBP22.2 million. Attrib...

Read more
1 Jun 22 11:45

Open Orphan's hVIVO wins GBP14.7 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said it's subsidiary hVIVO signed a GBP14.7 million contract for an influenza characterisation study and a follow on influenza human challenge study....

Read more
31 May 22 16:05

UK earnings, trading statements calendar - next 7 days

Wednesday 1 June  Impax Asset Management Group PLCHalf Year ResultsDr Martens PLCFull Year ResultsThursday 2 June  no events scheduled Friday  3 June  no events...

Read more
18 May 22 16:43

Open Orphan's hVIVO wins GBP7.3 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said its subsidiary hVIVO Ltd has signed a GBP7.3 million contract....

Read more
18 May 22 15:15

Open Orphan wins £7.3m human flu study contract

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed bio...

Read more
6 May 22 19:11

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:...

Read more
5 May 22 14:53

IN BRIEF: Open Oprhan wins contract for vaccine field site study

Open Orphan PLC - London-based pharmaceutical services - Subsidiary hVIVO is awarded new study with existing unnamed pharmacetical client to act as vaccination site for the client's respiratory syncyt...

Read more
13 Apr 22 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:...

Read more
1 Apr 22 20:23

IN BRIEF: Open Orphan Covid study results published in Nature Medicine

Open Orphan PLC - London-based pharmaceutical services - Says Thursday that results from the world's first Covid-19 characterisation study have been peer reviewed and published in the scientific journ...

Read more
25 Mar 22 14:10

IN BRIEF: Open Orphan wins GBP5 million human challenge study pact

Open Orphan PLC - London-based pharmaceutical services firm - Says its subsidiary, hVIVO, wins contract with a European biotechnology company for a human challenge study. The GBP5 million contract wit...

Read more
25 Mar 22 09:39

Open Orphan wins £5m contract for human study in RSV

(Sharecast News) - Open Orphan announced on Friday that its hVIVO subsidiary has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with an unnamed European biotechnolo...

Read more
8 Mar 22 19:37

IN BRIEF: Open Orphan expects to report profitable 2021 performance

Open Orphan PLC - London-based pharmaceutical services - For 2021, expects to report earnings before interest, tax, depreciation and amortisation, on revenue which is set to be GBP40 million, up from...

Read more
24 Feb 22 15:24

Open Orphan appoints Mo Khan as its new chief executive

(Sharecast News) - Contract research organisation Open Orphan announced the appointment of Yamin 'Mo' Khan as its chief executive officer on Thursday, with immediate effect....

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.